ITGA7

Jump to: navigation, search
VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Alpha-7 integrin is a protein that in humans is encoded by the ITGA7 gene.[1][2] Alpha-7 integrin is critical for modulating cell-matrix interactions. Alpha-7 integrin is highly expressed in cardiac muscle, skeletal muscle and smooth muscle cells, and localizes to Z-disc and costamere structures. Mutations in ITGA7 have been associated with congenital myopathies and noncompaction cardiomyopathy, and altered expression levels of alpha-7 integrin have been identified in various forms of muscular dystrophy.

Structure

ITGA7 encodes the protein alpha-7 integrin. Alpha-7 integrin is 128.9 kDa in molecular weight and 1181 amino acids in length.[3] Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. Alpha-7 integrin undergoes post-translational cleavage within the extracellular domain to yield disulfide-linked light and heavy chains that join with beta 1 to form an integrin that binds to the extracellular matrix protein laminin-1. The primary binding partners of alpha-7 integrin are laminin-1 (alpha1-beta1-gamma1), laminin-2 (alpha2-beta1-gamma1) and laminin-4 (alpha2-beta2-gamma1).[4] Alpha-7/beta-1 is the major integrin complex expressed in differentiated muscle cells.

Splice variants of alpha-7 integrin that differ in both the extracellular and cytoplasmic domains exist in the mouse[5] and are developmentally regulated in mouse and rat muscle tissue.[5][6][7][8][9] The X1/X2 alternative splicing region lies in the extracellular domain and alters the ligand binding site; specifically, the conserved homology repeat domains 3 and 4.[5] The first identified human transcript contains extracellular and cytoplasmic domains corresponding to the mouse X2 and B variants, respectively. A unique extracellular splice variant was also identified in human.[2][10] The differentially spliced variants detected in rodents have also been detected in humans. Major cytoplasmic, developmentally regulated variants, alpha-7A and alpha-7B, as well as extracellular variants, X1 and X2 were identified in humans. Moreover, the D variant, but not the C variant was detected in humans.[11]

Alpha-7 integrin is highly expressed in striated muscle, namely skeletal and cardiac muscle, and functions as the major laminin-binding integrin.[12] It was later shown that alpha-7 integrin is also highly expressed in smooth muscle.[13] The two major splice variants of alpha-7 integrin appear to have developmentally regulated expression; alpha-7A integrin is expressed solely in skeletal muscle, however alpha-7B integrin is expressed more loosely in striated muscle as well as the vasculature.[14]

Function

The function of alpha-7 integrin, as is the case for most integrins is to mediate cell membrane interactions with extracellular matrix.[15]

The alpha-7/beta-1 integrin complex clearly plays a role in the development of striated muscle and smooth muscle. Alpha-7/beta-1 integrin promotes the adhesion and motility of myoblasts, and is likely important in the recruitment of myogenic precursors during muscle differentiation.[16] It was shown however that beta-1D integrin appears at embryonic day 11 and alpha-7 integrin does not appear until embryonic day 17; thus, beta-1D associates with alternate alpha subunits (alpha-5, alpha-6A) prior to alpha-7.[17] In human skeletal muscle, alpha-7 integrin is also developmentally regulated, being first detected at age 2.[4]

In adult striated muscle cells, alpha-7 integrin (complexed to beta-1 integrin) is localized to Z-discs and costamere structures, bound to the four and one half LIM domain proteins, FHL1 and FHL2.[6][18][19] It has been demonstrated that alpha-7 integrin can be mono-ADP-ribosylated on the cell surface in skeletal muscle cells;[20] however, the functional significance of this modification has not been investigated.

Insights into the function of alpha-7 integrin have come from studies employing mouse transgenesis. A mouse expressing a null allele of the ITGA7 gene are viable, suggesting that alpha-7 integrin is not essential for normal myogenesis; however, these mice develop a phenotype that resembles muscular dystrophy. In soleus muscle, there was a significant disruption of myotendinous junctions, variation in the size of fibers, centrally located nuclei, necrosis, phagocytosis, and elevated serum levels of creatine kinase.[21] It has also been proposed that alpha-7 integrin and gamma-sarcoglycan have overlapping functions in skeletal muscle. In support of this, a double knockout of gamma-sarcoglycan and alpha-7 integrin produced a phenotype that was far worse than either knockout alone. Mice died within 1 month of birth and had severe muscle degeneration, suggesting that the roles of these proteins may overlap to maintain the stability of the sarcolemma.[22] Moreover, the double knockout of dystrophin and alpha-7 integrin produced a Duchenne muscular dystrophy-like phenotype, and demonstrated that alterations in alpha-7 integrin affect the pathological changes observed in dystrophin deficiencies.[23] In support of this notion, AAV overexpression of ITGA7 in skeletal muscle of Duchenne muscular dystrophy (DMD) mice showed a significant protective effect against adverse functional parameters associated with DMD, combined with a reversal of these negative features, suggesting that alpha-7 integrin may be a potential therapeutic candidate to treat Duchenne muscular dystrophy.[24]

Studies employing mutant alpha-7 integrin constructs have shown that the cytoplasmic tail of alpha-7B integrin is essential for regulation of lamellipodia formation and regulation of cell mobility regulation via laminin-1/E8 and p130(CAS)/Crk complex formation.[25]

Clinical Significance

Mutations in ITGA7 have been found in patients with unclassified congenital myopathy.[26] Additionally, in patients with severe congenital fiber type disproportion and left ventricular non-compaction cardiomyopathy, a missense mutation, Glu882Lys, was identified in ITGA7 along with a missense mutation in MYH7B, both novel disease genes having a synergistic effect on disease severity.[27]

Alpha-7B integrin expression has been shown to be significantly decreased at sarcolemmal membranes in patients with laminin alpha2 chain-deficient congenital muscular dystrophy. Additionally, in Duchenne muscular dystrophy and Becker muscular dystrophy, the expression of alpha-7B integrin was enhanced.[4]

Interactions

ITGA7 has been shown to interact with:

See also

References

  1. Wang W, Wu W, Desai T, Ward DC, Kaufman SJ (Aug 1995). "Localization of the alpha 7 integrin gene (ITGA7) on human chromosome 12q13: clustering of integrin and Hox genes implies parallel evolution of these gene families". Genomics. 26 (3): 568–70. doi:10.1016/0888-7543(95)80176-M. PMID 7607681.
  2. 2.0 2.1 "Entrez Gene: ITGA7 integrin, alpha 7".
  3. "Protein sequence of human ITGA7 (Uniprot ID: Q13683)". Cardiac Organellar Protein Atlas Knowledgebase (COPaKB). Retrieved 20 July 2015.
  4. 4.0 4.1 4.2 Cohn, RD; Mayer, U; Saher, G; Herrmann, R; van der Flier, A; Sonnenberg, A; Sorokin, L; Voit, T (1 March 1999). "Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle". Journal of the neurological sciences. 163 (2): 140–52. doi:10.1016/s0022-510x(99)00012-x. PMID 10371075.
  5. 5.0 5.1 5.2 Ziober, BL; Vu, MP; Waleh, N; Crawford, J; Lin, CS; Kramer, RH (15 December 1993). "Alternative extracellular and cytoplasmic domains of the integrin alpha 7 subunit are differentially expressed during development". The Journal of Biological Chemistry. 268 (35): 26773–83. PMID 8253814.
  6. 6.0 6.1 Maitra, N; Flink, IL; Bahl, JJ; Morkin, E (September 2000). "Expression of alpha and beta integrins during terminal differentiation of cardiomyocytes". Cardiovascular research. 47 (4): 715–25. doi:10.1016/s0008-6363(00)00140-1. PMID 10974220.
  7. Collo, G; Starr, L; Quaranta, V (5 September 1993). "A new isoform of the laminin receptor integrin alpha 7 beta 1 is developmentally regulated in skeletal muscle". The Journal of Biological Chemistry. 268 (25): 19019–24. PMID 8360188.
  8. Song, WK; Wang, W; Sato, H; Bielser, DA; Kaufman, SJ (December 1993). "Expression of alpha 7 integrin cytoplasmic domains during skeletal muscle development: alternate forms, conformational change, and homologies with serine/threonine kinases and tyrosine phosphatases". Journal of Cell Science. 106 (4): 1139–52. PMID 8126096.
  9. Ziober, BL; Kramer, RH (13 September 1996). "Identification and characterization of the cell type-specific and developmentally regulated alpha7 integrin gene promoter". The Journal of Biological Chemistry. 271 (37): 22915–22. PMID 8798472.
  10. Leung, E; Lim, SP; Berg, R; Yang, Y; Ni, J; Wang, SX; Krissansen, GW (4 February 1998). "A novel extracellular domain variant of the human integrin alpha 7 subunit generated by alternative intron splicing". Biochemical and Biophysical Research Communications. 243 (1): 317–25. doi:10.1006/bbrc.1998.8092. PMID 9473524.
  11. Vignier, N; Moghadaszadeh, B; Gary, F; Beckmann, J; Mayer, U; Guicheney, P (5 July 1999). "Structure, genetic localization, and identification of the cardiac and skeletal muscle transcripts of the human integrin alpha7 gene (ITGA7)". Biochemical and Biophysical Research Communications. 260 (2): 357–64. doi:10.1006/bbrc.1999.0916. PMID 10403775.
  12. Kaufman, SJ; Foster, RF; Haye, KR; Faiman, LE (June 1985). "Expression of a developmentally regulated antigen on the surface of skeletal and cardiac muscle cells". The Journal of Cell Biology. 100 (6): 1977–87. doi:10.1083/jcb.100.6.1977. PMC 2113591. PMID 3889014.
  13. Yao, CC; Breuss, J; Pytela, R; Kramer, RH (July 1997). "Functional expression of the alpha 7 integrin receptor in differentiated smooth muscle cells". Journal of Cell Science. 110 (13): 1477–87. PMID 9224765.
  14. Velling, T; Collo, G; Sorokin, L; Durbeej, M; Zhang, H; Gullberg, D (December 1996). "Distinct alpha 7A beta 1 and alpha 7B beta 1 integrin expression patterns during mouse development: alpha 7A is restricted to skeletal muscle but alpha 7B is expressed in striated muscle, vasculature, and nervous system". Developmental Dynamics. 207 (4): 355–71. doi:10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G. PMID 8950511.
  15. Hynes, RO (3 April 1992). "Integrins: versatility, modulation, and signaling in cell adhesion". Cell. 69 (1): 11–25. doi:10.1016/0092-8674(92)90115-s. PMID 1555235.
  16. Yao, CC; Ziober, BL; Sutherland, AE; Mendrick, DL; Kramer, RH (December 1996). "Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor". Journal of Cell Science. 109 (13): 3139–50. PMID 9004048.
  17. Brancaccio, M; Cabodi, S; Belkin, AM; Collo, G; Koteliansky, VE; Tomatis, D; Altruda, F; Silengo, L; Tarone, G (March 1998). "Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development". Cell adhesion and communication. 5 (3): 193–205. doi:10.3109/15419069809040291. PMID 9686317.
  18. Samson, T; Smyth, N; Janetzky, S; Wendler, O; Müller, JM; Schüle, R; von der Mark, H; von der Mark, K; Wixler, V (2 July 2004). "The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor". The Journal of Biological Chemistry. 279 (27): 28641–52. doi:10.1074/jbc.m312894200. PMID 15117962.
  19. Galie, PA; Khalid, N; Carnahan, KE; Westfall, MV; Stegemann, JP (NaN). "Substrate stiffness affects sarcomere and costamere structure and electrophysiological function of isolated adult cardiomyocytes". Cardiovascular Pathology. 22 (3): 219–27. doi:10.1016/j.carpath.2012.10.003. PMC 3610795. PMID 23266222. Check date values in: |date= (help)
  20. Zolkiewska, A; Moss, J (1997). "The alpha 7 integrin as a target protein for cell surface mono-ADP-ribosylation in muscle cells". Advances in experimental medicine and biology. 419: 297–303. PMID 9193669.
  21. Mayer, U; Saher, G; Fässler, R; Bornemann, A; Echtermeyer, F; von der Mark, H; Miosge, N; Pöschl, E; von der Mark, K (November 1997). "Absence of integrin alpha 7 causes a novel form of muscular dystrophy". Nature Genetics. 17 (3): 318–23. doi:10.1038/ng1197-318. PMID 9354797.
  22. Allikian, MJ; Hack, AA; Mewborn, S; Mayer, U; McNally, EM (1 August 2004). "Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle". Journal of Cell Science. 117 (Pt 17): 3821–30. doi:10.1242/jcs.01234. PMID 15252120.
  23. Guo, C; Willem, M; Werner, A; Raivich, G; Emerson, M; Neyses, L; Mayer, U (15 March 2006). "Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy". Human Molecular Genetics. 15 (6): 989–98. doi:10.1093/hmg/ddl018. PMID 16476707.
  24. Heller, KN; Montgomery, CL; Janssen, PM; Clark, KR; Mendell, JR; Rodino-Klapac, LR (March 2013). "AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice". Molecular Therapy. 21 (3): 520–5. doi:10.1038/mt.2012.281. PMC 3589167. PMID 23319059.
  25. Mielenz, D; Hapke, S; Pöschl, E; von Der Mark, H; von Der Mark, K (20 April 2001). "The integrin alpha 7 cytoplasmic domain regulates cell migration, lamellipodia formation, and p130CAS/Crk coupling". The Journal of Biological Chemistry. 276 (16): 13417–26. doi:10.1074/jbc.m011481200. PMID 11278916.
  26. Hayashi, YK; Chou, FL; Engvall, E; Ogawa, M; Matsuda, C; Hirabayashi, S; Yokochi, K; Ziober, BL; Kramer, RH; Kaufman, SJ; Ozawa, E; Goto, Y; Nonaka, I; Tsukahara, T; Wang, JZ; Hoffman, EP; Arahata, K (May 1998). "Mutations in the integrin alpha7 gene cause congenital myopathy". Nature Genetics. 19 (1): 94–7. doi:10.1038/ng0598-94. PMID 9590299.
  27. Esposito, T; Sampaolo, S; Limongelli, G; Varone, A; Formicola, D; Diodato, D; Farina, O; Napolitano, F; Pacileo, G; Gianfrancesco, F; Di Iorio, G (21 June 2013). "Digenic mutational inheritance of the integrin alpha 7 and the myosin heavy chain 7B genes causes congenital myopathy with left ventricular non-compact cardiomyopathy". Orphanet journal of rare diseases. 8: 91. doi:10.1186/1750-1172-8-91. PMC 3695851. PMID 23800289.
  28. Vachon, PH; Xu, H; Liu, L; Loechel, F; Hayashi, Y; Arahata, K; Reed, JC; Wewer, UM; Engvall, E (1 October 1997). "Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy". The Journal of Clinical Investigation. 100 (7): 1870–81. doi:10.1172/jci119716. PMC 508374. PMID 9312189.
  29. Hodges, BL; Hayashi, YK; Nonaka, I; Wang, W; Arahata, K; Kaufman, SJ (November 1997). "Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies". Journal of Cell Science. 110 (22): 2873–81. PMID 9427295.
  30. Vachon, PH; Xu, H; Liu, L; Loechel, F; Hayashi, Y; Arahata, K; Reed, JC; Wewer, UM; Engvall, E (1 October 1997). "Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy". The Journal of Clinical Investigation. 100 (7): 1870–81. doi:10.1172/jci119716. PMC 508374. PMID 9312189.
  31. 31.0 31.1 Samson T, Smyth N, Janetzky S, Wendler O, Müller JM, Schüle R, von der Mark H, von der Mark K, Wixler V (Jul 2004). "The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor". J. Biol. Chem. 279 (27): 28641–52. doi:10.1074/jbc.M312894200. PMID 15117962.

Further reading

External links


Linked-in.jpg